MARKET

NAYA

NAYA

NAYA Biosciences
NASDAQ
0.2127
-0.1084
-33.76%
After Hours: 0.2129 +0.0002 +0.09% 19:57 03/14 EDT
OPEN
0.2589
PREV CLOSE
0.3211
HIGH
0.2800
LOW
0.2080
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
3.500
52 WEEK LOW
0.2080
MARKET CAP
1.51M
P/E (TTM)
-0.0720
1D
5D
1M
3M
1Y
5Y
1D
*NAYA Biosciences: Reverse Stk Split to Bring Co Into Compliance Nasdaq Minimum Bid Price Requirement >NAYA
Dow Jones · 2d ago
*NAYA Biosciences Announces 1-for-12 Reverse Stk Split, Effective Pre-Market Opening on March 18>NAYA
Dow Jones · 2d ago
NAYA Announces 1-For-12 Reverse Stock Split Effective March 18, 2025
Benzinga · 2d ago
NAYA ANNOUNCES A 1:12 REVERSE STOCK SPLIT EFFECTIVE PRE-MARKET OPENING ON MARCH 18, 2025
Reuters · 2d ago
Weekly Report: what happened at NAYA last week (0303-0307)?
Weekly Report · 5d ago
Weekly Report: what happened at NAYA last week (0224-0228)?
Weekly Report · 03/03 10:37
NAYA Biosciences supports executive order on fertility treatment access
TipRanks · 02/25 13:41
Weekly Report: what happened at NAYA last week (0217-0221)?
Weekly Report · 02/24 10:37
More
About NAYA
More
NAYA Biosciences, Inc. formerly INVO Bioscience, Inc. operates the fertility business, as well as its focus to the development of clinical-stage assets in oncology and autoimmune diseases. The Company’s initial pipeline includes two novel Flex-NK Bispecific Antibodies. NY-303: its GPC3-targeted FLEX-NK Bispecific Antibody for Hepatocellular Carcinoma (HCC). NY-338: its CD38-targeted FLEX-NK Bispecific Antibody for Multiple Myeloma (MM) & Autoimmune Diseases. Its lead GPC3-targeting FLEX-NK bispecific antibody is entering Phase I/II clinical trials and positioned as a monotherapy option to address the unmet needs of the of hepatocellular carcinoma (HCC) patients not responding to standard of care with checkpoint inhibitors. INVOcell is its novel, FDA-cleared and CE-marked intravaginal culture (IVC) device. It offers a viable alternative to vitro fertilization (IVF) that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process.
Recently
Symbol
Price
%Change

Webull offers NAYA Biosciences Inc stock information, including NASDAQ: NAYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAYA stock methods without spending real money on the virtual paper trading platform.